Sleep Disorders Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with mild Alzheimer's disease, with a memory test score between 21 and 30 out of 30
- You are either not taking Alzheimer's medications (such as donepezil or memantine), or you have been on a stable dose of these medications for at least 3 months
- You are either not taking antidepressants or anxiety medications, or you stopped taking them at least 15 days ago
- You have a family member or carer who is able to fill in questionnaires, rating scales, and sleep diaries as part of the study
- You are willing and able to sign a consent form agreeing to take part
- You are able to attend all study visits and follow the study procedures
- You are registered with the French social security system
Who may not be able to join:
- You have a genetic (inherited) form of Alzheimer's disease
- There is not enough medical information available to confirm your Alzheimer's diagnosis
- You currently live in a care home or nursing home
- You are unable to read or are unable to complete psychological and behavioural tests
- You have significant physical or sensory problems (such as serious hearing or vision difficulties) that could interfere with the tests
- You are currently under a court or government restriction on your freedom
- You have been diagnosed with severe depression according to recognised medical guidelines (DSM-5)
- You are considered a protected adult under French law (confirm with trial site)
- You have a serious medical condition that is considered life-threatening in the short term
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Karim BENNYS, MD, University Hospital, Montpellier
Phone: +33467335219
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in the Alzheimer's Disease Cooperative Study - Preclinical Alzheimer Cognitive (ADCS-PACC) scale score
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.